Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Jackson

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Cell|June 16, 2012
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancerJames G Jackson, Vinod Pant, Qin Li, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2023
RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5Hyemin Lee, Ji Hoon Jung, Hyun Min Ko, et al.
Nature Cancer|December 9, 2022
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80Ashkan Shahbandi, Fang-Yen Chiu, Nathan A Ungerleider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53Shunbin Xiong, Huolin Tu, Madhusudhan Kollareddy, et al.
Cancer Research|September 17, 2020
Cancers from Novel <i>Pole</i>-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint BlockadeMelissa A Galati, Karl P Hodel, Miki S Gams, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Cell|June 16, 2012
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancerJames G Jackson, Vinod Pant, Qin Li, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2023
RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5Hyemin Lee, Ji Hoon Jung, Hyun Min Ko, et al.
Nature Cancer|December 9, 2022
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80Ashkan Shahbandi, Fang-Yen Chiu, Nathan A Ungerleider, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53Shunbin Xiong, Huolin Tu, Madhusudhan Kollareddy, et al.
Cancer Research|September 17, 2020
Cancers from Novel <i>Pole</i>-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint BlockadeMelissa A Galati, Karl P Hodel, Miki S Gams, et al.
Pageof 4